Avanott SRL
The score of Avanott shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +338 % Total assets +377 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Avanott's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 60,908 € | ||||
| Equity | 87,786 € | ||||
| Cash | 109,127 € | ||||
| EBITDA | 100,305 € | ||||
| Total assets | 127,081 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 18 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Avanott's financial analysis
- Solvency69.1%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Avanott
Avanott's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0542.894.449
- VAT number
- BE0542894449
- Peppol
- Registered · 0208:0542894449 · as of 31 Oct 2026
- Legal form
- SRL
- Incorporated
- 06 Dec 2013
- Registered office
- 3020 Herent
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Avanott (SRL) has been based in Herent since 2013, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 60,908 € and equity of 87,786 €; its revenue is not published. Its solvency stands at 69.1%, above the median of its sector (46.0%).
Companies similar to Avanott
Companies in the same business, of comparable size and area, outside its group.
- Medtradex Wholesale of pharmaceutical and medical goods Oud-Heverlee · balance sheet 952,747 €
- Linden API Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 12,520 €
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Accuray Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 257,954 €
- BVH Consulting Wholesale of pharmaceutical and medical goods Floreffe · balance sheet 44,707 €
- Labman Wholesale of pharmaceutical and medical goods Torhout · balance sheet 102,667 €
- Galenus Inc. Wholesale of pharmaceutical and medical goods Olen · balance sheet 126,374 €
- Liwaes Wholesale of pharmaceutical and medical goods Roosdaal · balance sheet 98,407 €
Frequently asked questions about Avanott
What is the revenue of Avanott?
Avanott files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Avanott?
In Belgium, the VAT number is the company number prefixed with BE: BE0542894449 for Avanott, if the company is VAT-registered. Its company number (CBE) is 0542.894.449.
Where is the registered office of Avanott?
According to the CBE register, the registered office of Avanott is in 3020 Herent.
What is the equity of Avanott?
At the close of the 2025 financial year, the equity of Avanott amounts to 87,786 €, a solvency of 69.1% of total assets.
Who manages Avanott?
The register lists 1 active mandates at Avanott. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Avanott
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →